BRIEF published on 03/24/2026 at 16:06, 1 month 16 days ago Northwest Biotherapeutics Gains Positive Outlook with Innovative Therapy Regulatory Approval Glioblastoma Treatment Northwest Biotherapeutics DCVax-L Therapy Oncology Innovations
BRIEF published on 03/24/2026 at 16:06, 1 month 16 days ago Northwest Biotherapeutics affiche des perspectives positives grâce à une thérapie innovante Traitement Du Glioblastome Approbation Réglementaire Biothérapies Du Nord-Ouest Thérapie DCVax-L Innovations En Oncologie
PRESS RELEASE published on 03/24/2026 at 16:01, 1 month 16 days ago Original-Research: Northwest Biotherapeutics Inc. (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research initiates coverage on Northwest Biotherapeutics Inc., with a Buy rating and USD 1.00 price target. Company is developing DCVax-L for glioblastoma First Berlin Equity Research BUY Rating Coverage Northwest Biotherapeutics Inc. DCVax-L
Published on 05/09/2026 at 01:30, 15 hours 5 minutes ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 16 hours 35 minutes ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 20:38, 19 hours 56 minutes ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 21 hours 22 minutes ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 21 hours 32 minutes ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 1 day 21 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 1 day 21 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 1 day 21 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 1 day 21 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 1 day 21 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
